RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer

被引:40
作者
Mahato, Arun Kumar [1 ]
Sidorova, Yulia A. [1 ]
机构
[1] Univ Helsinki, Inst Biotechnol, HiLIFE, Viikinkaari 5D, Helsinki 00014, Finland
基金
芬兰科学院;
关键词
rearranged in transfection (RET); neurodegeneration; obesity; cancer; RET agonist; neurorestoration; retinitis pigmentosa; hirschsprung disease; glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs); growth differentiation factor 15 (GDF15); MIDBRAIN DOPAMINERGIC-NEURONS; NEUROTROPHIC FACTOR; GDNF FAMILY; PARKINSONS-DISEASE; LIPID RAFTS; C-RET; FUNCTIONAL RECOVERY; TRANSFORMING GENE; MESSENGER-RNAS; MULLER GLIA;
D O I
10.3390/ijms21197108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rearranged during transfection (RET) is the tyrosine kinase receptor that under normal circumstances interacts with ligand at the cell surface and mediates various essential roles in a variety of cellular processes such as proliferation, differentiation, survival, migration, and metabolism. RET plays a pivotal role in the development of both peripheral and central nervous systems. RET is expressed from early stages of embryogenesis and remains expressed throughout all life stages. Mutations either activating or inhibiting RET result in several aggressive diseases, namely cancer and Hirschsprung disease. However, the physiological ligand-dependent activation of RET receptor is important for the survival and maintenance of several neuronal populations, appetite, and weight gain control, thus providing an opportunity for the development of disease-modifying therapeutics against neurodegeneration and obesity. In this review, we describe the structure of RET, its signaling, and its role in both normal conditions as well as in several disorders. We highlight the differences in the signaling and outcomes of constitutive and ligand-induced RET activation. Finally, we review the data on recently developed small molecular weight RET agonists and their potential for the treatment of various diseases.
引用
收藏
页码:1 / 21
页数:21
相关论文
共 142 条
[1]   The GDNF family: Signalling, biological functions and therapeutic value [J].
Airaksinen, MS ;
Saarma, M .
NATURE REVIEWS NEUROSCIENCE, 2002, 3 (05) :383-394
[2]   Constitutive and AP20187-induced ret activation in photoreceptors does not protect from light-induced damage [J].
Allocca, Mariacarmela ;
Di Vicino, Umberto ;
Petrillo, Marco ;
Carlomagno, Francesca ;
Domenici, Luciano ;
Auricchio, Alberto .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (11) :5199-5206
[3]   Tumor Evolution as a Therapeutic Target [J].
Amirouchene-Angelozzi, Nabil ;
Swanton, Charles ;
Bardelli, Alberto .
CANCER DISCOVERY, 2017, 7 (08) :805-817
[4]   Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site [J].
Anders, J ;
Kjær, S ;
Ibáñez, CF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) :35808-35817
[5]   Dynamics and control of the ERK signaling pathway: Sensitivity, bistability, and oscillations [J].
Arkun, Yaman ;
Yasemi, Mohammadreza .
PLOS ONE, 2018, 13 (04)
[6]  
Attié-Bitach T, 1998, AM J MED GENET, V80, P481, DOI 10.1002/(SICI)1096-8628(19981228)80:5<481::AID-AJMG8>3.0.CO
[7]  
2-6
[8]  
AVANTAGGIATO V, 1994, CELL GROWTH DIFFER, V5, P305
[9]   Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial) [J].
Backonja, Miroslav ;
Williams, Leslie ;
Miao, Xiaopeng ;
Katz, Nathaniel ;
Chen, Crystal .
PAIN, 2017, 158 (09) :1802-1812
[10]   Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRα3-RET receptor complex [J].
Baloh, RH ;
Tansey, MG ;
Lampe, PA ;
Fahrner, TJ ;
Enomoto, H ;
Simburger, KS ;
Leitner, ML ;
Araki, T ;
Johnson, EM ;
Milbrandt, J .
NEURON, 1998, 21 (06) :1291-1302